Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics

HBIO POWR Grades

• Sentiment is the dimension where HBIO ranks best; there it ranks ahead of 95.01% of US stocks.
• HBIO's strongest trending metric is Growth; it's been moving down over the last 179 days.
• HBIO ranks lowest in Momentum; there it ranks in the 38th percentile.

HBIO Stock Summary

• The price/operating cash flow metric for HARVARD BIOSCIENCE INC is higher than 96.87% of stocks in our set with a positive cash flow.
• Over the past twelve months, HBIO has reported earnings growth of -573.64%, putting it ahead of only 3.06% of US stocks in our set.
• Revenue growth over the past 12 months for HARVARD BIOSCIENCE INC comes in at -4.68%, a number that bests only 19.66% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to HARVARD BIOSCIENCE INC are FOXF, MIND, CRSR, CVV, and LFUS.
• Visit HBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.harvardbioscience.com.

HBIO Valuation Summary

• In comparison to the median Healthcare stock, HBIO's price/earnings ratio is 158.85% lower, now standing at -13.3.
• Over the past 243 months, HBIO's price/sales ratio has gone down 1.2.

Below are key valuation metrics over time for HBIO.

HBIO Growth Metrics

The 5 year net cashflow from operations growth rate now stands at 61.96%.
• The 2 year net cashflow from operations growth rate now stands at -119.77%.
• The 3 year net income to common stockholders growth rate now stands at -429.23%.

Over the past 49 months, HBIO's revenue has gone up $3,584,000.

The table below shows HBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	117.963	-1.41	-6.889
2022-06-30	120.704	-2.719	-3.654
2022-03-31	120.693	-1.761	-6.499
2021-12-31	118.904	1.262	-0.288
2021-09-30	116.833	3.635	-1.864
2021-06-30	111.207	5.892	-2.792

HBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HBIO has a Quality Grade of C, ranking ahead of 42.11% of graded US stocks.
• HBIO's asset turnover comes in at 0.728 -- ranking 27th of 75 Measuring and Control Equipment stocks.
• CAMT, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with HBIO.

The table below shows HBIO's key quality metrics over time.